Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3779940011 | Product containing only polatuzumab vedotin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3779941010 | Polatuzumab vedotin only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2821591000001118 | Polatuzumab vedotin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2821601000001110 | Polatuzumab vedotin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Polatuzumab vedotin | Is a | Product containing polatuzumab vedotin (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Polatuzumab vedotin | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Polatuzumab vedotin | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Polatuzumab vedotin | Has active ingredient | Polatuzumab vedotin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Polatuzumab vedotin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only polatuzumab vedotin in parenteral dose form (medicinal product form) | Is a | True | Polatuzumab vedotin | Inferred relationship | Existential restriction modifier | |
| Polatuzumab vedotin 30mg powder for solution for infusion vials | Is a | True | Polatuzumab vedotin | Inferred relationship | Existential restriction modifier | |
| Polatuzumab vedotin 140mg powder for solution for infusion vials | Is a | True | Polatuzumab vedotin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR